[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 716
Citations 0
Editorial
September 6, 2016

What Are the Facts About Autism Spectrum Disorders, Selective Serotonin Reuptake Inhibitors, and Assisted Reproductive Technology?

Author Affiliations
  • 1Section of Developmental-Behavioral Pediatrics, Department of Pediatrics, Nationwide Children's Hospital/The Ohio State University, Columbus
JAMA Pediatr. 2016;170(9):e161444. doi:10.1001/jamapediatrics.2016.1444

The last 2 decades have seen tremendous growth in the reported prevalence of autism spectrum disorders (ASD). They have moved from a relatively rare condition (perhaps 1 in 10 000) to a recently calculated 1 in 68 rate in the United States.1 The rapid rise has led to numerous theoretical explanations, with changes in diagnostic criteria and the possibility of diagnostic substitution standing apart from most. Other epidemiologic approaches that have considered what is different now compared with 30, 40, and 50 years ago and examined sociologic changes, public health policies, and environmental exposures have accumulated some degree of support for each of these.

First Page Preview View Large
First page PDF preview
First page PDF preview
×